N(1-(3-Methylbutanamido) N(1-Des(boric Acid))-d9 Bortezomib
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
N(1-(3-Methylbutanamido) N(1-Des(boric Acid))-d9 Bortezomib Product Information
N(1-(3-Methylbutanamido) N(1-Des(boric Acid))-d9 Bortezomib is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-96390.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
N(1-(3-Methylbutanamido) N(1-Des(boric Acid))-d9 Bortezomib
CAS No.
2714485-78-4
CAT No.
CS-T-96390
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C19H13D9N4O3
Molecular Weight
363.49
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
N(1-(3-Methylbutanamido) N(1-Des(boric Acid))-d9 Bortezomib is supplied with detailed characterization data compliant with regulatory guideline. N(1-(3-Methylbutanamido) N(1-Des(boric Acid))-d9 Bortezomib can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
"Isotope labelled N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer."
Synonyms
N(1-(3-Methylbutanamido) N(1-Des(boric Acid))-d9 Bortezomib
Application Notes
"Isotope labelled N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.